MISONIX, INC. (NASDAQ:MSON) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 12, 2017, Richard A. Zaremba agreed to step down, effective September 18, 2017 (the “Effective Date”), from his positions as Senior Vice President, Treasurer and Secretary of Misonix, Inc. (the “Company”). Mr. Zaremba will remain with the Company in a part-time, non-executive capacity. In addition to his current title of Chief Financial Officer, Joseph P. Dwyer assumed the titles of Treasurer and Secretary of the Company, as of the Effective Date.
On September 12, 2017, Mr. Zaremba and the Company entered into an amendment (the “Amendment”) to his existing severance letter agreement dated September 15, 2016 reflecting the effects of his part-time status. The Amendment is attached hereto as Exhibit 10.1, and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
(d)Exhibits – The following exhibit is filed as part of this report:
Exhibit No. Description of Exhibit
MISONIX INC ExhibitEX-10.1 2 s107496_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 September 18,…To view the full exhibit click
About MISONIX, INC. (NASDAQ:MSON)
MISONIX, INC. (Misonix) is a surgical device company. The Company designs, manufactures and markets therapeutic ultrasonic products across the world for spine surgery, skull-based surgery, neurosurgery, wound and burn debridement, cosmetic surgery, laparoscopic surgery and other surgical applications. The Company’s products include BoneScalpel, BoneScalpel MIS System, SonicOne O.R. System and SonaStar. BoneScalpel is an ultrasonic cutting system with applications in orthopedic and reconstructive surgery, as well as neurosurgery. BoneScalpel MIS System offers deep cuts through osseous structures with minimal blood loss. Misonix SonicOne O.R. System is an ultrasonic surgical debridement system that allows surgeons to address the challenges chronic wounds present to them, the patient, and the health-care system. SonaStar is used for neurosurgical procedures, such as skull/non-skull base tumor resections, transnasal procedures and acoustic mengiomas.